Sharon's Tru Story

Advanced non–small
cell lung cancer

Actor portrayal of Sharon, a real patient from the clinical trial. KEYTRUDA may not work for everyone, but this is her TRU STORY.

I want to get up
and fight this with all my might.
I want to be there for my family. 

Sharon, on battling her cancer

Actor portrayal of Sharon, a real patient from the clinical trial. KEYTRUDA may not work for everyone, but this is her TRU STORY.

Sharon is all about family. She’s married with grown children who visit every weekend. She’s worked in a factory most of her life and takes pride in the hard work she’s done. Her inner strength served her well when she was diagnosed with advanced
non–small cell lung cancer. Throughout her life, others have noticed her fighting spirit, including her reverend, who told her that she was one of the strongest fighters he'd ever known.

Sharon's story on TV 

Patient Stories for Those Treated With KEYTRUDAPatient Stories for Those Treated With KEYTRUDA

Life Before Cancer

Sharon began to feel tired and had pain in her back. Though she had back pain before, this was different—she knew something was wrong. Her doctor ordered some tests and found a tumor on her tailbone.

After weeks of additional testing, Sharon learned that she had advanced non–small cell lung cancer that had spread to other parts of her body, including her tailbone. Without treatment for her lung cancer, Sharon was given a few months to live. She thought first of her children—how would the news affect them?

 

Journey to
Diagnosis

Sharon thought she would have to start chemotherapy. Sharon was thinking of her mother who went through the same thing, and she felt as if she knew what to expect. But, Sharon’s doctor had done a biomarker test that showed her tumor had high levels of PD-L1. She learned she could join a clinical trial where she received KEYTRUDA instead of chemotherapy.

Learn more about PD-L1 testing 

Patient Stories for Those Treated With KEYTRUDAPatient Stories for Those Treated With KEYTRUDA

Treatment with
KEYTRUDA

After starting KEYTRUDA, Sharon had a scan every few months. Her results during the trial showed that her tumor was shrinking, and she began to feel better. “The scans were showing good news,” she said.

Learn about clinical trial data with KEYTRUDA 

Although some days are better than others and she can feel tired while on treatment, Sharon’s here 1 year later to share her story. She wants others to know that there’s a treatment for people whose tumors have high levels of
PD-L1, and it’s different than chemotherapy. Sharon’s own experience with KEYTRUDA has given her more time with the most important people in her life—her family.

Experiences with KEYTRUDA differ among individuals. KEYTRUDA will not work for everyone, and it's important to be informed about possible side effects. Always talk to your doctor or health care team if you have questions about your treatment.

Learn about side effects with KEYTRUDA 

 
 

Ask Your Health Care Team if KEYTRUDA® (pembrolizumab) Is Right for You

Ask your health care team if KEYTRUDA is right for you

Want more info about KEYTRUDA?

Sign up for regular updates 

Need help talking to
your doctor?

Download a doctor
discussion guide 

For more information or to sign up over the phone, call 85-KEYTRUDA (855-398-7832)(855-398-7832).


Please scroll for full indication

KEYTRUDA is used to treat a kind of lung cancer called non–small cell lung cancer (NSCLC). KEYTRUDA may be used as your first treatment option when your lung cancer has spread (advanced NSCLC) and tests positive for “PD-L1” and your tumor does not have an abnormal “EGFR” or “ALK” gene.

KEYTRUDA may also be used for advanced NSCLC if you have tried chemotherapy that contains platinum and it did not work or is no longer working and your lung cancer tests positive for PD-L1 and if your tumor has an abnormal EGFR or ALK gene, you have received an EGFR or ALK inhibitor medicine that did not work or is no longer working.

It is not known if KEYTRUDA is safe and effective in children less than 18 years of age.

PD-L1 = programmed death ligand 1;
EGFR = epidermal growth factor receptor;
ALK = anaplastic lymphoma kinase.


Ask Your Health Care Team if KEYTRUDA® (pembrolizumab) Is Right for You

Ask your health care team if KEYTRUDA is right for you

Want more info about KEYTRUDA?

Sign up for regular updates 

Need help talking to
your doctor?

Download a doctor
discussion guide 

For more information or to sign up over the phone, call 85-KEYTRUDA (855-398-7832)(855-398-7832).

Important Risk Information About KEYTRUDA® (pembrolizumab)

KEYTRUDA is a medicine that may treat your lung cancer by working with your immune system. KEYTRUDA® (pembrolizumab) can cause your immune system to attack normal organs and tissues in many areas of your body and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.

Call or see your doctor right away if you develop any symptoms of the following problems or these symptoms get worse:

Lung problems (pneumonitis). Symptoms of pneumonitis may include shortness of breath, chest pain, or new or worse cough.

Intestinal problems (colitis) that can lead to tears or holes in your intestine. Signs and symptoms of colitis may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness.

Liver problems (hepatitis). Signs and symptoms of hepatitis may include yellowing of your skin or the whites of your eyes, nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine, feeling less hungry than usual, or bleeding or bruising more easily than normal.

Hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas). Signs and symptoms that your hormone glands are not working properly may include rapid heartbeat, weight loss or weight gain, increased sweating, feeling more hungry or thirsty, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, muscle aches, dizziness or fainting, or headaches that will not go away or unusual headache.

Kidney problems, including nephritis and kidney failure. Signs of kidney problems may include change in the amount or color of your urine.

Problems in other organs. Signs of these problems may include rash, changes in eyesight, severe or persistent muscle or joint pains, severe muscle weakness, or low red blood cells (anemia).

Infusion (IV) reactions, that can sometimes be severe and life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, shortness of breath or wheezing, itching or rash, flushing, dizziness, fever, or feeling like passing out.

Getting medical treatment right away may help keep these problems from becoming more serious. Your doctor will check you for these problems during treatment with KEYTRUDA. Your doctor may treat you with corticosteroid or hormone replacement medicines. Your doctor may also need to delay or completely stop treatment with KEYTRUDA if you have severe side effects.

Before you receive KEYTRUDA, tell your doctor if you have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus; have had an organ transplant; have lung or breathing problems; have liver problems; or have any other medical problems.

If you are pregnant or plan to become pregnant, tell your doctor. KEYTRUDA can harm your unborn baby. Females who are able to become pregnant should use an effective method of birth control during treatment and for at least 4 months after the final dose of KEYTRUDA. Tell your doctor right away if you become pregnant during treatment with KEYTRUDA.

If you are breastfeeding or plan to breastfeed, tell your doctor. It is not known if KEYTRUDA passes into your breast milk. Do not breastfeed during treatment with KEYTRUDA and for 4 months after your final dose of KEYTRUDA.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Common side effects of KEYTRUDA include feeling tired, itching, diarrhea, decreased appetite, rash, shortness of breath, constipation, and nausea.

These are not all the possible side effects of KEYTRUDA. Tell your doctor if you have any side effect that bothers you or that does not go away. For more information, ask your doctor or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please read the accompanying Medication Guide for KEYTRUDA® (pembrolizumab) and discuss it with your doctor. The physician Prescribing Information also is available.


E-mail a friend

Share this website about a treatment option for advanced non–small cell lung cancer. No personal information (including e-mail addresses) about you or your friend will be collected from this e-mail notification feature offered by Merck.